Chronic inflammatory disorders are one of the biggest health problems in America today. This application describes the Comprehensive Center for Inflammatory Disorders whose mission is to support the identification and implementation of the full range of discovery from research on the basic mechanisms of inflammation to improved methods in the prevention and treatment of oral and systemic inflammatory diseases and disorders. The goals of the Center are to: 1) integrate studies on the fundamental mechanisms of cellular responses to inflammatory stimuli to better understand the basis of cellular activation, motility, and function that occur during inflammatory responses; 2) integrate basic research studies on inflammation with animal, patient-based and population research to better understand the cellular and molecular basis of oral inflammatory disorders; 3) identify several new and innovative approaches to the prevention, diagnosis, and treatment of chronic inflammation and facilitate their development into effective interventions for the treatment of oral and systemic inflammatory diseases and disorders within 5 years; 4) utilize and expand ongoing research on community education, screening, counseling, and related service programs to find better ways to expand public implementation of new advances in the prevention, diagnosis, and treatment of chronic oral and systemic inflammatory diseases and disorders; 5) integrate discovery from laboratory, clinical, population, education or community-based research into ongoing Center activities or new Center initiatives; and 6) promote programs for the education of health professionals and the public on the etiology, prevention, diagnosis, and treatment of chronic inflammatory diseases and disorders. The Center consists of 4 workgroups in the areas of fundamental, clinical, epidemiologic, and community outreach and outcomes research which are supported by an administrative, educational, technology transfer, and research support core. This Center core is designed to: 1) stimulate sharing, mutual interpretation, and integration of information on inflammation or inflammatory disorders obtained through research discovery; 2) provide mechanisms that allow the rapid development of discovery into new research projects, therapies, interventions, or potentially marketable products; 3) educate health professionals and the public on health issues of oral and systemic inflammatory disorders; and 4) make available to each product essential administrative support, research facilities, research services, coordination, and scientific leadership.

National Institute of Health (NIH)
National Institute of Dental & Craniofacial Research (NIDCR)
Comprehensive Center (P60)
Project #
Application #
Study Section
Special Emphasis Panel (ZDE1-YS (10))
Program Officer
Mangan, Dennis F
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Schools of Dentistry
Chapel Hill
United States
Zip Code
Arce, R M; Caron, K M; Barros, S P et al. (2012) Toll-like receptor 4 mediates intrauterine growth restriction after systemic Campylobacter rectus infection in mice. Mol Oral Microbiol 27:373-81
Qian, Li; Wu, Hung-ming; Chen, Shih-Heng et al. (2011) ?2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol 186:4443-54
Arce, R M; Diaz, P I; Barros, S P et al. (2010) Characterization of the invasive and inflammatory traits of oral Campylobacter rectus in a murine model of fetoplacental growth restriction and in trophoblast cultures. J Reprod Immunol 84:145-53
Maile, Laura A; Busby, Walker H; Nichols, Timothy C et al. (2010) A monoclonal antibody against alphaVbeta3 integrin inhibits development of atherosclerotic lesions in diabetic pigs. Sci Transl Med 2:18ra11
Lemmon, Christopher A; Chen, Christopher S; Romer, Lewis H (2009) Cell traction forces direct fibronectin matrix assembly. Biophys J 96:729-38
Qian, Li; Hu, Xiaoming; Zhang, Dan et al. (2009) beta2 Adrenergic receptor activation induces microglial NADPH oxidase activation and dopaminergic neurotoxicity through an ERK-dependent/protein kinase A-independent pathway. Glia 57:1600-9
Light, Kathleen C; Bragdon, Edith E; Grewen, Karen M et al. (2009) Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. J Pain 10:542-52
Williams, Ray C (2008) Understanding and managing periodontal diseases: a notable past, a promising future. J Periodontol 79:1552-9
Qian, Li; Wei, Sung-Jen; Zhang, Dan et al. (2008) Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol 181:660-8
Qian, Li; Flood, Patrick M (2008) Microglial cells and Parkinson's disease. Immunol Res 41:155-64

Showing the most recent 10 out of 70 publications